Although α7-nAChR is the oncogenic receptor responsible for most of the oncogenic responses in cancer, α9-nAChR has been shown to be upregulated in estrogen receptor positive breast cancer cells, and α9-nAChR stimulates the initiation and progression of breast cancer in coalition with estrogen receptor [95]. The gene discussed is ESR1; the disease is cancer.